Acquired Factor XIII Deficiency Is Common during ECMO Therapy and Associated with Major Bleeding Events and Transfusion Requirements.

Background: Bleeding events are frequent complications during extracorporeal membrane oxygenation therapy (ECMO).

Objective: To determine the rate of acquired factor XIII deficiency and its association with major bleeding events and transfusion requirements in adults undergoing ECMO therapy.

Materials And Methods: A retrospective single centre cohort study.